Jane Street’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$373K Buy
79,107
+17,833
+29% +$84.2K ﹤0.01% 4049
2025
Q1
$281K Buy
61,274
+37,661
+159% +$173K ﹤0.01% 4635
2024
Q4
$113K Sell
23,613
-41,678
-64% -$200K ﹤0.01% 5300
2024
Q3
$306K Sell
65,291
-45,605
-41% -$214K ﹤0.01% 4844
2024
Q2
$627K Buy
110,896
+48,992
+79% +$277K ﹤0.01% 4284
2024
Q1
$254K Sell
61,904
-31,311
-34% -$129K ﹤0.01% 4791
2023
Q4
$393K Sell
93,215
-149,541
-62% -$631K ﹤0.01% 4383
2023
Q3
$1.05M Buy
242,756
+199,963
+467% +$864K ﹤0.01% 2888
2023
Q2
$282K Buy
+42,793
New +$282K ﹤0.01% 4316
2023
Q1
Hold
0
6264
2022
Q4
Hold
0
6314
2022
Q2
Hold
0
6329
2022
Q1
Hold
0
6234
2021
Q4
Sell
-10,743
Closed -$184K 5956
2021
Q3
$184K Buy
10,743
+408
+4% +$6.99K ﹤0.01% 4445
2021
Q2
$222K Sell
10,335
-7,422
-42% -$159K ﹤0.01% 4333
2021
Q1
$267K Sell
17,757
-2,549
-13% -$38.3K ﹤0.01% 4017
2020
Q4
$267K Sell
20,306
-13,353
-40% -$176K ﹤0.01% 3250
2020
Q3
$326K Buy
+33,659
New +$326K ﹤0.01% 2794
2020
Q1
Sell
-23,414
Closed -$384K 3995
2019
Q4
$384K Buy
+23,414
New +$384K ﹤0.01% 2472
2018
Q2
Sell
-15,282
Closed -$258K 3777
2018
Q1
$258K Buy
+15,282
New +$258K ﹤0.01% 2637
2017
Q2
Sell
-22,187
Closed -$311K 3280
2017
Q1
$311K Sell
22,187
-3,960
-15% -$55.5K ﹤0.01% 2206
2016
Q4
$417K Sell
26,147
-4,048
-13% -$64.6K ﹤0.01% 1888
2016
Q3
$503K Buy
30,195
+12,322
+69% +$205K ﹤0.01% 1870
2016
Q2
$200K Buy
+17,873
New +$200K ﹤0.01% 2367
2015
Q3
Hold
0
2941
2015
Q2
Hold
0
2875
2015
Q1
Sell
-15,454
Closed -$221K 2537
2014
Q4
$221K Sell
15,454
-17,709
-53% -$253K ﹤0.01% 1527
2014
Q3
$344K Buy
+33,163
New +$344K ﹤0.01% 1471
2014
Q2
Sell
-16,144
Closed -$262K 2875
2014
Q1
$262K Buy
+16,144
New +$262K ﹤0.01% 1842